Clinical trial · Interventional
Group Metacognitive Therapy for Anxiety and Depression in Cancer Survivors
An Open Trial of Group Metacognitive Therapy for Anxiety and Depression in Cancer Survivors
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Covid-19 halted study, reorganisation of the clincial service and staff leaving posts made recruitement to a group unfeasible
Summary
Brief summary (as posted)
This study aims to test the potential of group metacognitive therapy in alleviating emotional distress in cancer survivors. The investigators aim to find out if a group based approach is acceptable to patients and feasible to deliver in a routine clinical health psychology service.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Anxiety | — | UNRESOLVED | — |
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Depression | — | UNRESOLVED | — |
| Quality of Life | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Group Metacognitive Therapy | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Group Metacognitive Therapy
- description
- Group metacognitive therapy (MCT) is a brief psychological intervention designed to be delivered in small groups of 4-8 patients over a course of six, 90 minute sessions conducted on a weekly basis
- interventionNames
- Behavioral: Group Metacognitive Therapy
Primary outcomes (1)
- measure
- Hospital Anxiety Depression Scale-Total (HADS-Total)
- timeFrame
- Change in HADS total at up to 10 weeks through study completion
- description
- Measures severity of emotional distress
Secondary outcomes (5)
- measure
- Cognitive Attentional Syndrome-1 (CAS-1)
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Cancer diagnosis at least 6 months previously * A score of at least 15 on the Total scale score of the Hospital Anxiety and Depression Scale (HADS) * Sufficient understanding of English to consent and engage in therapy * Stable on, or free from, psychotropic medication * Minimum of 18 years old Exclusion Criteria: * History of psychotic disorder, learning disability, or organic mental disorder * Risk of self-harm or suicide warranting immediate intervention * In palliative phase of treatment * Being considered for risk-reducing or reconstructive surgery within 1 year * Concurrent psychological intervention for emotional distress * Cognitive impairment precluding informed consent or participation * Undergoing acute medical treatment (e.g. chemotherapy, radiotherapy) * Current drug/alcohol abuse
References
Publications (0)
Data not yet available